Trading status Status de
  • Prices realtime
    • Indizes
      • UC DAX
      • UC MDAX
      • UC TECDAX
      • UC DJI
      • UC ESTOXX
      • UC NASQAD 100
    • Shares
    • ETFs & FUNDS
    • Bonds
    • Crypto
  • Screen markets
    • Stock screener
    • Certifcate Screener
    • ETF Screener
    • Fund Screener
    • Bond screener
  • Trading ideas
    • risk indices
      • risk indices
      • EU Intraday
      • EU Long Term
      • US Intraday
      • US Longterm
    • New on gettex
      • New listings stocks
      • New listings bonds
      • New intraday certificates
    • Blog
    • Newsletter
    • Watchlist
    • Support
  • Trading
    • Trading Calendar
    • Extended trading hours
    • Listing on demand
    • Announcements
    • Quality Reports
    • Delayed Data
    • Regulations
    • Become a Trade Participant
    • Cancellations
  • About Gettex
    • FAQs
    • Press
    • Partners
    • Committees
    • Career
    • Career
    • Service & Contact
  • Why gettex

News overview

  • «
  • ‹
  • …
  • 11638
  • 11639
  • 11640
  • …
  • ›
  • »

2024-10-31

Oncimmune Holdings shares tick up as notes new contracts

2024-10-31

Transition Industries LLC and Mitsubishi Gas Chemical Announce Letter of Intent for a Long-Term Methanol Sales Agreement From the Pacifico Mexinol Project in Sinaloa, Mexico

2024-10-31

Invitation to the presentation of New Wave Group′s interim report for January-September 2024

2024-10-31

Tangiamo and Trustplay Begin Development on New AI-Powered Game Studio

2024-10-31

Glaston makes a change to the Executive Leadership Team

2024-10-31

FTSE 100 live: Index slides to new 12-week low, Smith & Nephew and Kainos plunge

2024-10-31

Nippon Sanso Holdings reports Q2 results

2024-10-31

Fluidra, S.A. 9M GAAP EPS of EUR 1.01, revenue of EUR 1.64B

2024-10-31

Forte Minerals Corp: Forte Minerals Completes Miscanthus Acquisition from Globetrotters Resource Group

2024-10-31

ANA Expects Record Full-Year Revenue

2024-10-31

PharmaDrug Inc.: PharmaDrug′s Sairiyo Therapeutics Announces Successful Completion of Stability Study of PD-001 (Patented Reformulated Cepharanthine) to Support Use in Phase 1 Study for Viral Infectious Diseases

2024-10-31

Change in the number of shares and votes in AddLife AB

  • «
  • ‹
  • …
  • 11638
  • 11639
  • 11640
  • …
  • ›
  • »

Preset online depot

Favorites: Zertifikate-Finder FAQs Newsletter
Tradingtime Mo-Fr: 7:30-23 h
Certificates 8:00-22 h
  • Imprint
  • Legal notice
  • Data protection
  • Contact
  • Cookies